Neurocrine Biosciences | Lånekapital

Loan Capital Endring Dato
Acadia Pharmaceuticals USD 0 0 2022-06
Amgen USD 63.17B 4.13B 2023-12
Cytokinetics USD 607.37M 1.65M 2023-12
Dynavax Technologies USD 222.7M 283K 2023-12
Exelixis USD 0 0 2022-03
Gilead Sciences USD 23.19B 1.98B 2023-09
Halozyme Therapeutics USD 1.5B 1.63M 2023-12
Intra Cellular Therapies USD 0 0 2022-06
Ionis Pharmaceuticals USD 1.23B 49.79M 2023-12
Neurocrine Biosciences USD 169.5M 500K 2023-03
Prothena USD 0 0 2022-06
Repligen USD 0 0 2022-06
Teva Pharmaceutical Industries USD 18.5B 203M 2023-09
Ultragenyx Pharmaceutical USD 0 0 2022-06
Vertex Pharmaceuticals USD 390.3M 13.8M 2023-09



Neurocrine Biosciences Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - May 2024.